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The use of the white cell count and haemoglobin in
combination as an effective screen to predict the
normality of the full blood count
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INTRODUCTION
The full blood count (FBC) is one of the most fre-
quently requested pathological tests by clinicians and
usually comprises 13–19 parameters with additional
parameters continuously being introduced (Lewis,
Bain & Bates, 2006).
The clinical utility of this test is vast; an increased
or decreased total white blood cell count (WBC) could
be due to abnormal bone marrow pathology (Leguit &
van den Tweel, 2010). Leucocytosis with an associated
neutrophilia or lymphocytosis could infer the presence
of a microbial or viral infection (Estridge, Reynolds &
Walters, 2000). A decrease in the WBC could also be
caused by a chemotoxic effect during chemotherapy
(Debled et al., 2007). Clinicians can use the WBC bio-
marker to improve risk prognostication and identify
patients in need of immediate treatment and a closer
follow-up (Paladino et al., 2010). A decrease in the red
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SUMMARY
Introduction: The utility of the full blood count (FBC) is vast with
each parameter serving as a tool to aid diagnosis and monitor disease
progression. However, the effectiveness of the test is hampered
because of increased workload and lack of interpretation. In the
effort to redress this issue, the combined use of the white blood cell
count (WBC) and haemoglobin in predicting the normality of the
FBC is evaluated.
Method: FBC data were collated from 2191 patients and classiﬁed into
two groups depending on whether the WBC and the haemoglobin
were within the reference range. Blood ﬁlms were examined on the
abnormal FBC samples in each group and graded on morphology.
Results: The FBC was normal in 89.6% of cases in the presence of a
normal WBC and haemoglobin with subtle abnormalities in the
remainder; 1+ grading of abnormal morphology in 93%. However,
when the WBC and/or haemoglobin was abnormal, the remaining
FBC was signiﬁcantly abnormal (P < 0.05) and the corresponding
blood ﬁlms were grossly abnormal; 2+/3+ grading in 96% of cases.
Conclusion: We concluded that in the presence of a normal WBC and
haemoglobin, the FBC is normal in almost all cases and measuring
these two parameters could be used as an effective screen to predict
FBC normality.
Re-use of this article is permitted in accordance with the
Terms and Conditions set out at http://wileyonlinelibrary.
com/onlineopen#OnlineOpen_Terms.
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and depending on the red cell indices values, the aeti-
ology of the anaemia can be deduced (Trent, 2006).
The rate of increase in haemoglobin could be used to
monitor the treatment of anaemia and determine the
amount of blood required for transfusion (Taher,
Musallam & Inati, 2009; Tettey et al., 2009). The plate-
let count and its size can also be used to determine
the thrombopoietic activity of the bone marrow, and
an increase or decrease in platelet numbers can also
point to disorders of haemostasis (Radaelli et al., 2007)
or liver disease (Adams, 2010).
The effectiveness of the FBC has been hampered
because of a lack of appropriate screening, which in
turn results in data overload (Miyakis et al., 2006). A
survey on clinicians and nurses revealed that nine of 10
end-users only utilized the WBC, haemoglobin and
platelet of the 13 parameters reported routinely from
the FBC proﬁle because of either a lack of application or
interpretation and time constraints (Pennycook, 1995).
Another reason for the underutilization of FBC
data is the situation of large workload in most labora-
tories, such that those who are capable of interpreting
all parameters within a FBC proﬁle are inundated
owing to the volume. As a result, decisions and
follow-up actions on abnormal laboratory results are
slowed down (Miyakis et al., 2006).
Autovalidation criteria, which involve computerised
algorithms to fast-track validation to transmit normal
FBCs to the hospital information system, may reduce
the workload on laboratory staff interpreting data and
enable efﬁcient procession of results; however, it would
not resolve the issue of time and cost involved in analy-
sing such large numbers of samples (Birkmeyer et al.,
2002). Therefore, there has been a rising demand to
increase the diagnostic effectiveness of this test through
appropriate screening (Pennycook, 1995; Miyakis et al.,
2006; Hawkins, 2007). With the advent of point-of-care
testing, there are a few devices that measure single pri-
mary parameters such as WBC or haemoglobin accu-
rately by a minute capillary (ﬁnger prick) sample
(Morris, 2007; Osei-Bimpong et al., 2009). Supporting
such appropriate developments could represent oppor-
tunities for laboratory medicine to help inﬂuence the
scope of future service delivery (Beastall, 2008). Testing
for speciﬁc individual parameters on such devices is
usually very quick with results obtained within min-
utes, and such testing is also low in cost (Morris, 2007;
Osei-Bimpong et al., 2009). The utility of an individual
parameter such as the WBC or the haemoglobin, how-
ever, offers a limited and partial picture in the diagnosis
(Kho et al., 2007). Although it has been shown from a
previous study that in majority of cases where the hae-
moglobin was within the normal range, the remainder
of the FBC was normal (Lewis, Osei-Bimpong & Brad-
shaw, 2004), there are signiﬁcant numbers where the
WBC may be abnormal in the presence of a normal
haemoglobin, notably in individuals with mild to mod-
erate infections (Murphy et al., 2007). Conversely, in
the presence of a normal WBC, it is still possible to have
a low haemoglobin and abnormal red cell indices, espe-
cially with most cases of nutritional anaemia
(Subramanian, Kitson & Bhaniani, 2009). Thus, in such
categories of patients, it is therefore not effective to
screen or conclude comprehensively that the FBC is
normal based on a single parameter such as the WBC or
haemoglobin.
However, the utility of the WBC and haemoglobin in
combination as a possible screen to predict the normal-
ity of the FBC has never been assessed; in this study, we
determine the effectiveness of the use of the WBC in
conjunction with the haemoglobin value to determine
the outcome of the FBC; we determine the nature of the
FBC proﬁle when the WBC and the Haemoglobin are (i)
both within the normal reference range and (ii) beyond
the reference range. We compare the different extents
of the FBC and blood ﬁlm abnormalities in both groups.
METHODS
Over a 5-week period, FBC data were collated from a
randomized selection of 2191 patients who had the
test requested by their clinician in the Hammersmith
Hospital Imperial College Healthcare Trust. The test
served as an adjunct for the investigation of the
underlying conditions.
This population included 42.6% women and 57.4%
men, and the age range was 16–91 years. These com-
prised 39% of the patients referred from general prac-
titioners, while 33% were hospitalized inpatients and
the remainder were from outpatient departments.
Sample collection
The samples were collected in 3-mL BD vacutainer
 
bottles (Becton Dickinson, Crowley, UK) containing
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were processed in their fresh state according to the
standard laboratory protocol.
To control the nature of the counts more effec-
tively, all samples were taken in the morning to con-
trol circadian rhythmic inﬂuences on the counts
(Smaaland et al., 2002).
FBC analysis
The analyser on which the FBC samples were pro-
cessed was the standard Sysmex XE2100 FBC analyser
(Sysmex Corporation, Kobe, Japan); the analyser was
adequately controlled by Internal Quality control that
involved running an e-check
  control once daily and
also running a Levy–Jennings quality control pro-
gramme to calculate the moving average for every 20
samples.
Access to all pathology test results, medical history
and medication on each patient included in this study
was obtained from the Laboratory and Hospital Infor-
matics Systems.
Reference range and screened groups
The reference range used for the FBC proﬁle was estab-
lished by locally deriving working reference values
(Table 1) taking into account the wide age range of 16–
91 years and the use a of a representative population
(Lewis, Bain & Bates, 2006). The FBC data were then
classiﬁed into two groups, i.e. normal screened group
and abnormal screened groups depending on whether
both the WBC and the haemoglobin were within or
beyond the normal reference range.In each of the two
groups, the number of samples that had the remaining
FBC parameters within the reference range was
recorded. Any sample that triggered an analyser ﬂag
was also classiﬁed as the abnormal group.
Blood ﬁlms
A corresponding blood ﬁlm was prepared from all
abnormal screened samples and examined microscopi-
cally in line with the standard laboratory procedure.
The blood ﬁlms were examined for morphological fea-
tures and cell counts to verify the FBC and any associ-
ated analyser ﬂags. The degree of abnormality was
categorized using the ‘plus’ grading scale (HKTMA
Haematology and Serology panel, 2002). The main
morphological features and their associated grading
criteria are shown in Table 2. Grading of the morpho-
logical abnormality was based on percentage or abso-
lute numbers of cell subtypes observed in a 200-white
cell differential under low-power magniﬁcation.
(NCCLS, 1991).
Statistical Methods
All data were analysed using Excel software statistics
package analysis software (Microsoft Ofﬁce Excel
 
2003); in each of the two groups, the range and the
standard deviation were calculated.
Student’s paired t-tests were also calculated
using this package; P-values <0.05 were considered
signiﬁcant.
Table 1. Full blood count reference range
Parameters Reference range
Reference range
mean
White cell count
(WBC)
4–11 · 10
9/L 7.5 · 10
9/L
Haemoglobin (Hb)
(men)
13.0–17.0 g/dL 15.0 g/dL
Haemoglobin
(women)
12.0–15.0 g/dL 13.5 g/dL
Platelets (Plt) 120–410 · 10
9/L 275 · 10
9/L
Neutrophils 2.0–8.0 · 10
9/L 5.0 · 10
9/L
Lymphocytes 1.0–3.5 · 10
9/L 2.3 · 10
9/L
Monocytes 0.1–1.0 · 10
9/L 0.6 · 10
9/L
Eosinophils 0.01–0.7 · 10
9/L 0.4 · 10
9/L
Basophils 0.01–0.1 · 10
9/L 0.06 · 10
9/L
Red cell count
(RBC) (men)
3.80–5.50 · 10
12/L 4.7 · 10
12/L
RBC (women) 3.60–4.80 · 10
12/L 4.2 · 10
12/L
Mean cell volume
(MCV)
83–101 fL 92 fL
Mean cell
haemoglobin
(MCH)
26–32 pg 29 pg
Mean cell
haemoglobin
concentration
(MCHC)
31–35 pg 33 pg
Haematocrit
(HCT) (men)
0.40–0.50 L/L 0.45 L/L
Haematocrit
(women)
0.35–0.45 L/L 0.40 L/L
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A total of 939 FBC proﬁles were within the normal
screened group where both the WBC and haemoglobin
(Hb) values fell within the normal reference range:
WBC = 4–11 · 10
9/L and Hb 13–17 g/dL (men), Hb
12–15 g/dL (women). In this group, there were 841
(89.6%) samples in which the remainder of the FBC
was also within the normal reference range, i.e. there
were only 98 cases in which there was an abnormal
parameter/analyser ﬂag for the remaining FBC.
In the abnormal screened group where either or
both WBC and haemoglobin fell outside the reference
limits, there were 1252 FBC proﬁles in this group,
and in all cases, there was an additional parameter
with a value beyond the reference limit, i.e. none of
the samples in this latter category had a normal value
for the remaining FBC parameters.
In both groups, the numbers of samples were clas-
siﬁed detailing the numbers of cases outside the limits
for each of the FBC parameters (Tables 3 and 4). A
morphology comment was made on the correspond-
ing blood ﬁlm from each sample. (Table 5) The degree
of abnormality was also evaluated and veriﬁed by
examining the corresponding blood ﬁlms of the sam-
ples with abnormal FBC values; these were further
classiﬁed/graded depending on the degree of abnor-
mality.
DISCUSSION
All white cell, red cell and platelet parameter ranges
were signiﬁcantly closer to the corresponding refer-
ence range in the normal screened group in compari-
son with the abnormal screened group: Within the
normal screened group, the WBC differential was nor-
mal in most cases, and the data range for each of the
white cell subtypes was signiﬁcantly narrower in com-
parison with the abnormal screened group (Table 3),
(P < 0.05). We observed that there were considerably
few patients in the normal screened group (1.9%
beyond the reference limit for neutrophils) and the
deviation was subtle and clinically insigniﬁcant; all
their corresponding blood ﬁlms reﬂected normal mor-
phology (Table 5). It has been shown that these
slightly abnormal counts are usually caused by physi-
ological changes associated with certain conditions
such as pregnancy whereby the count returns to nor-
mal after delivery (Dale & Liles, 2003), and also
abnormally low neutrophil counts are found in
approximately 25–50% of persons of African descent
who have benign ethnic neutropenia without evi-
dence of increased susceptibility to infection or any
other adverse effects (Haddy, Rana & Castro, 1999).
The red cells and their indices were also within the
normal reference limits in most cases when the WBC
and the haemoglobin were normal (Table 4). The red
Table 2. Morphological observation classiﬁcation criteria
Morphological observation 1+ abnormal grading 2+ abnormal grading 3+ abnormal grading
Thrombocytosis (Plt · 10
9/L) 411–500 501–650 >650
Thrombocytopenia (Plt · 10
9/L) 100–119 50–99 <50
Granulocytosis (WBC · 10
9/L) 9–17 18–26 >26
Granulocytopenia (WBC · 10
9/L) 0.5–1.0 0.25–0.49 <0.25
Lymphopenia (WBC · 10
9/L) 0.5–1.0 0.25–0.49 <0.25
Lymphocytosis/variant forms >6% >12% >18%
Monocytosis >7% >14% >21%
Eosinophilia >7% >14% >21%
Immature leucocytes/left shift >7% >14% >21%
Nucleated red cells >2% >4% >6%
Hypochromia 2–4% 5–7% 8–20%
Microcytosis 5–20% 21–50% 51–75%
Macrocytosis 2–10% 11–25% 26–50%
Polychromasia 3–5% 5–25% >25%
Red cell inclusions <1% 2–3% >3%
Spherocytosis 1–5% 5–25% >25%
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of cases in comparison with the abnormal screened
group where 39% of patients had an abnormal red cell
count. The degree to which they were abnormal was
also signiﬁcantly wider (P < 0.05), and the SD values
were higher in all red cell parameters. On examining
the corresponding blood ﬁlms of samples beyond the
reference range within the normal screened category,
none of the morphological features were classiﬁed as
>1+ grading (Table 5). The haematinics were also
checked; B12, serum folate and the iron status in these
patients were all found to be within the normal ranges,
and in these patients, the marginally low red cell
indices may be attributed to heterozygous cases of hae-
moglobinopathies, such as alpha thalassaemia minor,
most of which are asymptomatic (Hattori, 2002).
The platelet count was outside the normal refer-
ence range in only 2.2% of samples with a normal
WBC and haemoglobin. However, when either or
both the WBC and haemoglobin were abnormal, a
normal platelet count was beyond the reference range
in 29.1% of cases and the degree to which the value
deviated from the normal range was signiﬁcantly
higher (platelet count range: 8–812 · 10
9/L, P < 0.05)
in comparison with the cases where both the WBC
and the haemoglobin were normal (platelet count
range: 93–477 · 10
9/L).
Thus, we have shown such an effective screen that
measures WBC and haemoglobin to assure laboratory
and/or clinical staff of the high probability of FBC
normality. This could streamline the numbers to
enable laboratory staff to focus on interpreting abnor-
mal FBCs to optimize patient care more speedily and
effectively; testing can be streamlined to identify and
focus on more likely abnormal FBC and blood ﬁlms.
In cases where the WBC and haemoglobin are nor-
mal, resources could be then channelled into carrying
out other pathological tests instead to arrive at a cor-
rect diagnosis. In that way, maximum information
would be obtained from laboratory tests to provide
greatest beneﬁt at least cost.
Another advantage of measuring only WBC and
haemoglobin is the speed, with a WBC achieved in
minutes using the Hemocue WBC
  (Osei-Bimpong
et al., 2009) and the haemoglobin obtainable within a
minute using the Hemocue Hb 301
  (HemoCue AB,
Angelholm, Sweden); the key advantage of such
point-of-care testing is the rapid time from sampling
to the result being involved in a clinical decision
(Morris, 2007).
Occasionally, there are difﬁculties in obtaining ade-
quate sample for an FBC in some patients because of
collapsed veins, and most of these cases, the clinician
may just need to ascertain whether there has been an
adequate increment in the haemoglobin, post-transfu-
sion or whether there has been an adequate response
to antibiotics reﬂected in the resolve of a leucocytosis;
in such cases, a ﬁnger prick to determine the WBC or
haemoglobin would sufﬁce, and with the advent of
devices, within which these parameters can be deter-
mined accurately, there would be a high utility.
In developing countries, and in many rural primary
health centres, this may be the more cost-effective
approach compared with the running of a FBC, mak-
ing savings on the sample tubes and the FBC analyser
reagents. A further beneﬁt could be to reduce the tra-
vel of patient to a location where FBC testing is per-
formed. Point-of-care testing of the WBC and
haemoglobin may offer greater area coverage espe-
cially in the rural or under-resourced population
Table 5. Morphology grading distribution on blood ﬁlm for samples with analyser ﬂag/full blood count (FBC) values
beyond reference limits
% No. of
samples with
normal ﬁlm
% No. of samples
with abnormal ﬁlm
of 1+ grading
% No. of samples
with abnormal ﬁlm
of 2+ grading
% No. of samples
with abnormal ﬁlm
of 3+ grading
Normal screened group failing
reference limits for remaining
FBC parameters (N = 98)
79 3 0 0
Abnormal screened group failing
reference limits for remaining
FBC parameters (N = 1252)
0 4 64 32
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Mendelow, 2006). It could also be of value, especially
in general practice and in rural clinics without access
to FBC analysers.
There are also numerous circumstances where ade-
quate facilities may not be readily available for full
proﬁle diagnostic tests such as the FBC, especially in
disaster areas and war zones (Kost et al., 2006), and a
speedy diagnostic technique may be required; the
determination of the WBC and the haemoglobin could
be an effective screen to triage any potentially abnormal
FBCs to warrant further haematological investigations.
CONCLUSION
We have shown that in a wide and largely randomized
selection of FBCs, in majority of cases where the WBC
and the haemoglobin are within the normal range, the
remainder of the FBC proﬁle is normal as well.
In a minority of cases, where the WBC and the
haemoglobin are normal, the FBC proﬁle could have
one or more parameters outside the reference range;
however, the degree is remarkably subtle and of little
clinical signiﬁcance.
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